WuXi Biologics China

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

View original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-announces-research-service-agreement-with-biontech-on-discovering-investigational-monoclonal-antibodies-for-developing-next-generation-therapeutic-product-candidates-302031587.html